PRESS RELEASE: IVI Releases 2022 Annual Report
Alexandria, VA – July 13, 2023 – The Innovation and Value Initiative (IVI), a non-profit research organization committed to advancing the science, practice, and use of health technology assessment (HTA) in healthcare, today announced [...]
IVI Responds to the ICER 2023 Value Assessment Framework
IVI submitted comments on the ICER 2023 Value Assessment Framework. We appreciate the opportunity to provide comments on this important issue. In revising its value assessment framework, IVI recommends that ICER make modifications related [...]
PRESS RELEASE: IVI Submits Comments on FDA’s Patient-Focused Drug Development Program
Alexandria, VA – July 11, 2023 – The Innovation and Value Initiative (IVI), a non-profit research organization committed to advancing the science, practice, and use of health technology assessment (HTA) in healthcare, submitted comments [...]
IVI Announces Leadership Update
It is with mixed emotions we announce that Jennifer Bright, MPA, will be stepping down from her position as Chief Strategy and Engagement Officer effective June 30th. Ms. Bright joined IVI in 2017 and [...]
PRESS RELEASE: Healthcare Research Organization Releases Patient-Centered Decision-Making Guidelines
Alexandria, VA – June 14, 2023 – The Innovation and Value Initiative (IVI), a non-profit research organization committed to advancing the science, practice, and use of health technology assessment (HTA) in healthcare, today announced [...]
PRESS RELEASE: IVI and AcademyHealth Release Economic Impacts Framework
Alexandria, VA – June 7, 2023 – The Innovation and Value Initiative (IVI), a non-profit research organization committed to advancing the science, practice, and use of health technology assessment in healthcare, in partnership with [...]
IVI Partners with AcademyHealth to Address Economic Impacts on Patients and Caregivers
IVI, in partnership with AcademyHealth, released a joint report, “A Research Framework to Understand the Full Range of Economic Impacts on Patients and Caregivers,” for researchers, value assessors, and other decision-makers to address the [...]
IVI MEMBER SPOTLIGHT: Richard Seiden, JD
Richard Seiden, retired attorney and patient advocate, is a member of the IVI Patient Advisory Council, where he provides valuable insight into IVI's work. In a recent conversation, Richard shared how psoriatic arthritis has [...]
PRESS RELEASE: Non-Profit Research Organization Makes Patient-Centered Recommendations to CMS for Medicare DPNP
Alexandria, VA – May 5, 2023 – The Innovation and Value Initiative (IVI), a non-profit research organization committed to advancing the science, practice, and use of health technology assessment (HTA) in health care, submitted comments [...]
IVI Comments on CMS’ Medicare Drug Price Negotiation Program
IVI submitted comments on the Centers for Medicare and Medicaid Services' (CMS) initial guidance for the implementation of the Medicare Drug Price Negotiation Program (Medicare DPNP). We appreciate the opportunity to provide comment on [...]
IVI Co-Authors Manuscript with the RAND Corporation
IVI is pleased to share our recently published manuscript, co-authored with the RAND Corporation, in the Journal of Comparative Effectiveness Research. For this manuscript, IVI collaborated with a steering committee and surveyed patients with [...]
Bringing One Health Journey Forward: An Interview with Shannan O’Hara-Levi about the Economic Impacts of Rheumatoid Arthritis
In 2021, the Innovation and Value Initiative (IVI) and the Arthritis Foundation published a report, First Hand Perspectives in Rheumatoid Arthritis, describing how researchers often miss the priorities and needs of people living with [...]